Publications

Analyzing Vaccine Trials in Epidemics with Mild and Asymptomatic Infection.

Author(s): Kahn R, Hitchings M, Wang R, Bellan S, Lipsitch M|Journal: Am J Epidemiol|PMID: 30329134| October 2018

Vaccine efficacy against susceptibility to infection (VES), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with…

Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.

Author(s): Kahn R, Hitchings M, Bellan S, Lipsitch M|Journal: Clin Trials|PMID: 29374974| April 2018

Background/aims Network structure and individuals' level of exposure to a pathogen can impact results from efficacy evaluation studies of interventions…